March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Nanotechnology Guided Molecular Imaging of Choroidal Neovascularization
Author Affiliations & Notes
  • Colin A. Bretz
    Vanderbilt Eye Institute, Vanderbilt Univ Med Center, Nashville, Tennessee
  • Ashwath Jayagopal
    Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee
  • Footnotes
    Commercial Relationships  Colin A. Bretz, None; Ashwath Jayagopal, None
  • Footnotes
    Support  P30-EY008126 (Core Grant in Vision Research), International Retinal Research Foundation, Unrestricted Grant from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3006. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Colin A. Bretz, Ashwath Jayagopal; Nanotechnology Guided Molecular Imaging of Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3006. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Strategies for the early detection of choroidal neovascularization are needed to facilitate timely therapeutic intervention and to monitor disease progression and treatment response. Ligand-coated nanoparticles were developed for site-specific imaging of neovascular lesions in animal models of laser-induced choroidal neovascularization.

Methods: : Infrared dyes and fluorescent semiconducting nanocrystals (quantum dots) were conjugated to peptides or antibodies directed against vascular cell adhesion molecule 1 (VCAM-1), an early marker of choroidal neovascularization, using covalent conjugation techniques. Negative controls were synthesized incorporating scrambled peptide or nonspecific antibody conjugated imaging agents. Conjugates were injected in mouse models of laser-induced choroidal neovascularization at timepoints up to 31 days post laser injury, and age matched controls. Ocular tissue was imaged ex vivo and in vivo throughout the time course of choroidal neovascularization for evaluation of specificity and sensitivity.

Results: : VCAM-1 targeted imaging agents were capable of early detection of choroidal neovascularization via binding to VCAM-1. VCAM-1 signal remained elevated throughout the time course of pathology, up to 1 month post laser injury. Signal to background ratios of VCAM-1 specific imaging agents ranged from 10-25:1 depending on the disease timepoint, and fluorescence emission was focal to CNV lesions. Negligible binding of imaging agents was observed in control animals.

Conclusions: : Successful detection of early choroidal neovascularization was possible in the mouse model of laser induced choroidal neovascularization. Molecular imaging of the eye is a promising strategy for facilitating early detection of disease, which may improve clinical management of neovascular AMD.

Keywords: imaging/image analysis: non-clinical • choroid: neovascularization • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×